Lawnicki Lyle C, Rubocki Ronald J, Chan Wing C, Lytle Deborah M, Greiner Timothy C
Department of Pathology and Microbiology, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 68198, USA.
J Mol Diagn. 2003 May;5(2):82-7. doi: 10.1016/s1525-1578(10)60456-4.
Limited data exist regarding the distribution of gene segments used in T-cell receptor gamma gene rearrangements (TCR gamma GR) in T-cell lymphoproliferative disorders. The reported efficacy of TCR gamma GR protocols ranges from 60% to greater than 90%. Laboratories reporting a lower detection rate tend to use a limited set of primers. The goal of our study was to provide TCR gamma GR data to demonstrate the molecular biological basis for needing multiple primer sets targeting all gene segments. Sixty cases with a confirmed histological diagnosis of a T-cell lymphoproliferative disorder and TCR gamma GR were identified in our lymphoma registry from 1995 to 2001. DNA was obtained from fresh/frozen tissue, cell lysates, or paraffin-embedded tissue. Variable (V gamma) region gene segments were identified using denaturing gradient gel electrophoresis, which was used to select the cases in the study. Capillary electrophoresis using fluorescent-labeled joining (J gamma) region primers was performed to identify J gamma segments. Sixty cases contained a total of 98 TCR gamma GR, as some cases have more than one rearrangement. The most frequent gene segment combination involved the V gamma 1-8 and J gamma 1/2 segments. If a single primer set directed at these two segments were used for clinical diagnosis, that pair of primers would only diagnose 67% of cases as positive for TCR gamma GR. Our gene segment distribution data emphasize the importance of using a comprehensive set of V gamma and J gamma primers for an optimal detection rate of TCR gamma GR. Protocols with limited numbers of primers should be reconsidered.
关于T细胞增殖性疾病中T细胞受体γ基因重排(TCRγGR)所使用基因片段的分布,现有数据有限。报道的TCRγGR方案的有效率在60%至90%以上。报告检测率较低的实验室倾向于使用有限的一组引物。我们研究的目的是提供TCRγGR数据,以证明需要针对所有基因片段使用多组引物的分子生物学基础。1995年至2001年期间,我们在淋巴瘤登记处确定了60例经组织学确诊为T细胞增殖性疾病且进行了TCRγGR检测的病例。DNA取自新鲜/冷冻组织、细胞裂解物或石蜡包埋组织。使用变性梯度凝胶电泳鉴定可变(Vγ)区基因片段,该方法用于选择研究中的病例。使用荧光标记的连接(Jγ)区引物进行毛细管电泳以鉴定Jγ片段。60例病例共有98次TCRγGR重排,因为有些病例有不止一次重排。最常见的基因片段组合涉及Vγ1-8和Jγ1/2片段。如果将针对这两个片段的单一引物组用于临床诊断,那对引物只能将67%的病例诊断为TCRγGR阳性。我们的基因片段分布数据强调了使用一套完整的Vγ和Jγ引物以实现TCRγGR最佳检测率的重要性。应重新考虑引物数量有限的方案。